Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Dynamic Semiconductors Invesco ETF (PSI)

Dynamic Semiconductors Invesco ETF (PSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
7 Semiconductor Stocks That Could Make You a Millionaire Motley Fool - Mon Jul 15, 4:38AM CDT

Yes, Nvidia is one of them. But it's not the only semiconductor game in town.

NVDA : 128.44 (-0.62%)
TSM : 185.22 (-1.14%)
INTC : 34.46 (-0.09%)
AVGO : 171.42 (+0.80%)
QCOM : 208.18 (+2.84%)
MPWR : 870.91 (+1.78%)
MU : 130.87 (-2.01%)
SOXX : 260.18 (+0.11%)
SMH : 273.83 (-0.23%)
XSD : 268.80 (+1.02%)
PSI : 66.24 (+1.16%)
Missed Out on Nvidia? Buy the Invesco Semiconductors ETF (PSI) Instead. Motley Fool - Fri May 10, 2:21AM CDT

Is Nvidia getting too big for your portfolio? This semiconductor ETF offers a unique form of smart diversification.

IVZ : 16.22 (+1.19%)
PSI : 66.24 (+1.16%)
SMH : 273.83 (-0.23%)
SOXX : 260.18 (+0.11%)
NVDA : 128.44 (-0.62%)

Barchart Exclusives

1 Big Pharma Dividend Stock to Snag While It's Still Cheap Barchart - Mon Jul 15, 6:30PM CDT
Pfizer's stock presents a compelling investment opportunity, trading at an attractive valuation with a high dividend yield, as the company makes promising progress on its oral obesity drug, danuglipron, in a market dominated by injectable treatments. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot